Upload
medresearch
View
275
Download
2
Embed Size (px)
DESCRIPTION
Citation preview
1
Human Pancreatic Islets and Human Pancreatic Islets and Diabetes ResearchDiabetes Research
J.S. Kaddis, B.J. Olack, J. Sowinski, J. Cravens, J.L. Contreras, J.C. Niland
JAMA, April 15, 2009; V 301, No. 15
Presented byJohn S. Kaddis
Support Scientist, Department of Information SciencesCity of Hope National Medical Center
Beckman Research Institute
2
Human Islet Based ResearchHuman Islet Based Research
• Goal– One day, cure diabetes mellitus
• Value– Prevent development of the disease– Expand therapeutic options for those with
diabetes – Understand uniqueness of human islet biology
• Challenges– Human islets are difficult to manufacture,
cannot be stored, and are not readily renewable
3
Availability of Human Islets Allows Availability of Human Islets Allows Studies Relevant to Human Studies Relevant to Human DiabetesDiabetes
Pancreas
Organ Donations
Human Islets
Pancreas Processing
Ship by overnight courier to scientists Basic Science
Laboratory Research
4
Availability of Human Islets Allows Availability of Human Islets Allows Studies Relevant to Human Studies Relevant to Human DiabetesDiabetes
Pancreas
Deliver to Transplant
Center
Human Islets
Clinical Islet Transplantation
Right image adapted from: Naftanel MA, Harlan DM. Pancreatic Islet Transplantation. PLoS Medicine. 2004, 1(3), e58, 198-201
Organ Donations
Pancreas Processing
5
Need for Human IsletsNeed for Human Islets
•156 approved studies
•>15% annual increase in production
•>25% annual increase in demand
•Need supplied
•100% in 2004•46% in 2008
6
Islet Cell Resource (ICR) Islet Cell Resource (ICR) ConsortiumConsortium
Image Source: http://icr.coh.org/icr_map.asp (accessed April 9, 2009)
ICR Laboratories
•8 currently active •Competitive grant application and renewal process
Facility Qualifications•External Audit Compliance w/ cGMP•Clinical Proficiency
Responsibilities•Provide human islets: Basic Research Clinical Use•Improve human islet isolation and transplantation technologies
Data Coordinating Center•Central Office, Administrative Functions•Biostatistics, Biomedical Informatics
7
Studies Using Human IsletsStudies Using Human Islets
• 182 ICR Supported Studies– 26 Transplantation Protocols (Table 1)
• 15 (57%) Islet Alone• 5 (19%) Islet After Kidney• 3 (11%) Simultaneous Islet Kidney• 3 (11%) Double Arm• Data available on 186 of 201 clinical use
pancreata– Multiple transplants per patient
» 99 patients» 170 transplants
– In some cases, greater than 1 pancreas per transplant
– 156 Basic Science Laboratory Studies (Table 2)
8
Results Reported By Collaborative Results Reported By Collaborative Islet Transplant RegistryIslet Transplant Registry
Figure Source: Alejandro R et al. Update from the Collaborative Islet Transplant Registry. Transplantation. 2008, 86, 1783-1788.
Insulin Independence Graft Function
Benefits of Transplant• Reduction or
elimination of severe hypoglycemic unawareness
• Stabilization of blood sugar levels
• Alleviation of need for insulin
• Improvement in patient quality of life
9
Obstacles in Islet Transplantation Obstacles in Islet Transplantation
• Islet death• Limited engraftment• Chronic immunosuppression• Alloimmunity• Autoimmunity• Limited supply of human islets
10
156 Diabetes Research Projects 156 Diabetes Research Projects Supported by the ICR Supported by the ICR Consortium Consortium
Study Type Islets Distributed Extramural Funding
n Number % n Amount %
Prevention and Treatment
86 39,662,677 56 54 $54,713,969 66
Pathophysiology 18 7,056,630 10 11 $5,922,294 7
Both 43 22,289,392 31 25 $21,958,061 26
Data Not Reported 9 2,125,500 3 3 $635,429 1
TOTALS 156 71,134,199
100 93 $83,229,753
100•Certain studies require more islets than others e.g.: Islet/beta-cell imaging and assessment
•Studies requiring fewer islets are greater in number e.g.: Beta cell growth/differentiation, Cell signaling and regulation
•Projects range in cost from: Low of $193,600 (beta-cell regeneration, survival, and death) High of $3.2 million (pharmaceutical research and drug testing)
11
Islet Production by ICR ConsortiumIslet Production by ICR Consortium
•Pancreata used predominately in basic science laboratory research (75%)
•Islet yield Clinical transplantation: 91,633,202 / 201 = 455,886 Basic science research: 199,427,452 / 805 = 247,735 Not used: 6,503,022 / 66 = 98,531
•Very little unused
12
Organ Donation in the United Organ Donation in the United States 2001-2008States 2001-2008
0 10000 20000 30000 40000 50000 60000
Organ Donors
OPTN data last updated: April 3, 2009 for donations occurring through January 31, 2009
13
Organ Donation in the United Organ Donation in the United States 2001-2008States 2001-2008
0 10000 20000 30000 40000 50000 60000
Kidney
Organ Donors
OPTN data last updated: April 3, 2009 for donations occurring through January 31, 2009
14
Organ Donation in the United Organ Donation in the United States 2001-2008States 2001-2008
0 10000 20000 30000 40000 50000 60000
Intestine
Lung
Pancreas
Heart
Liver
Kidney
Organ Donors
OPTN data last updated: April 3, 2009 for donations occurring through January 31, 2009
Whole Px ?
15
General Measurement Data General Measurement Data from Pancreas Donorsfrom Pancreas Donors
16
Gender and Medical History Gender and Medical History of Pancreas Donorsof Pancreas Donors
17
Facility OperationsFacility Operations
Image Source: Ricordi C, Strom TM. Clinical Islet Transplantation: Advances and Immunological Challenges. Nature Reviews Immunology. 2004, 4, 259-268.
• $1 million - $7 million to establish facility
• $0.8 million - $3 million annual facility maintenance
• $21,000 estimated direct costs for processing each pancreas*
*Estimation Based on Data From: Frank A et al. Transplantation for Type I Diabetes: Comparison of Vascularized Whole-Organ Pancreas with Isolated Pancreatic Islets. Annals of Surgery. 2004, 240(4), 631-643.
18
Standard Acquisition Charges Standard Acquisition Charges for Pancreata Acquired by ICR: 2001-for Pancreata Acquired by ICR: 2001-20082008
Organ Use
Basic Science Research
Clinical Transplant
Not Used
Number of Pancreata
561 86 18
Median Cost (Low, High)
$3000 ($600-
$39,800)
$20,350 ($1,500-$39,800)
$4000($1,600-$16,000)
19
Alternatives to Using Human IsletsAlternatives to Using Human Islets
• Surrogates for Human Beta Cells – Main benefit: Restoration of beta cell function – Disadvantages: Pleiotropy, oncogenic
potential, autoimmune properties poorly understood, long term metabolic function
• Cell Lines – Benefits: Low cost, limited variability of
samples, preliminary experiments– Disadvantages: Same
• Nonhuman Islets– Benefits: Easier to isolate, inexpensive
20
Using Non-Human IsletsUsing Non-Human Islets
Figure Source: Cabrera O et al. The Unique Cytoarchitecture of Human Pancreatic Islets has Implication for Islet Cell Function. Proceedings of the National Academy of Sciences. 2006, 103 (7), 2334-2339.
Differences seen in:• Number of cells within an
islet • Islet architecture • Beta cell response to
drugs
21
ConclusionsConclusions
• Pancreas donations crucial• Islet sharing networks play a key role in
scientific and therapeutic research• Clinical transplantation has proven value• Basic science laboratory research necessary
to understand diabetes mellitus• Human islets play a key role in restoration
of beta cell function• Adequate resources necessary to ensure
local, regional, and national access to human islets9 20
42
83
120
158
48
38
37
41
2211
90
50
100
150
200
250
2002 2003 2004 2005 2006 2007 2008
New Publications
Existing Publications
22
AcknowledgementsAcknowledgements
Funding AgenciesFunding AgenciesDepartment of Health and Human Services, National Institutes of Health; National Center for Research Resources National Institute of Diabetes and Digestive and Kidney DiseasesJuvenile Diabetes Research Foundation
Human Islet Isolation Laboratories Human Islet Isolation Laboratories Washington University, T. Mohanakumar; 2001-2006University of Colorado, R.G. Gill; 2001-2006University of Tennessee, A.O. Gaber; 2001-2006Puget Sound Blood Center, J. Reems; 2001-2006Joslin Diabetes Center, G. Weir; 2001-2006Columbia University, M.A. Hardy; 2001-2006University of Minnesota, B.A. Hering; 2001-2009University of Pennsylvania, A. Naji; 2001-2009University of Miami, C. Ricordi; 2001-2009City of Hope (COH) National Medical Center, F. Kandeel; 2001-2009University of Wisconsin, L. Fernandez; 2006-2009Chicago Consortium; University of Illinois at Chicago, J. Oberholzer; 2006-2009 Northwestern University, D. Kaufman; 2006-2009University of Alabama Birmingham, J.L. Contreras; 2006-2009
Organ Donors and their FamiliesOrgan Donors and their Families
People with DiabetesPeople with Diabetes
23
AcknowledgementsAcknowledgements
Islet Isolation, Laboratory and Clinical Research DataIslet Isolation, Laboratory and Clinical Research DataIslet Cell Resources Administrative and Bioinformatics Coordinating Center, COH; Martha Antler Tracey Stiller
Clinical Transplant and Organ Donor DataClinical Transplant and Organ Donor DataCollaborative Islet Transplant Registry, EMMES CorporationOrgan Procurement and Transplantation Network United Network for Organ Sharing
OtherOtherVanderbilt University, Alvin PowersUniversity of Pittsburgh, Andrew Stewart
Background Islet ImageBackground Islet ImageInstitute for Molecular Bioscience at the University of Queensland in Australia, Brad Marsh